<?xml version="1.0" encoding="ISO-8859-1"?>
<BiblioData DataBase="ESPACENET" Version="221" Datum="2012-07-14">
<SubDatabase>
espacenet
</SubDatabase>
<Title>
LUMINESCENT PARTICLE AND METHOD OF DETECTING A BIOLOGICAL ENTITY USING A LUMINESCENT PARTICLE
</Title>
<PublicationNumber>
EP1955074A2
</PublicationNumber>
<Inventor>
<Name>
VAN DER ZAAG PIETER JAN [DE]
</Name>
<Name>
BAKKERS ERIK PETRUS ANTONIUS M [DE]
</Name>
<Name>
VAN DER MARK MARTINUS BERNARDU [DE]
</Name>
<Name>
VAN DER ZAAG, PIETER, JAN
</Name>
<Name>
BAKKERS, ERIK, PETRUS, ANTONIUS, MARIA
</Name>
<Name>
VAN DER MARK, MARTINUS, BERNARDUS
</Name>
</Inventor>
<Applicant>
<Name>
KONINKL PHILIPS ELECTRONICS NV [NL]
</Name>
<Name>
KONINKLIJKE PHILIPS ELECTRONICS N.V
</Name>
</Applicant>
<RequestedPatent>
EP1955074
</RequestedPatent>
<ApplicationElem>
<Number>
EP20060821496
</Number>
</ApplicationElem>
<ApplicationDate>
2006-11-20
</ApplicationDate>
<PriorityElem>
<PriorityNumber>
WO2006IB54330
</PriorityNumber>
<PriorityDate>
2006-11-20
</PriorityDate>
<PriorityNumber>
EP20050111075
</PriorityNumber>
<PriorityDate>
2005-11-22
</PriorityDate>
<PriorityNumber>
EP20060821496
</PriorityNumber>
<PriorityDate>
2006-11-20
</PriorityDate>
</PriorityElem>
<IPC>
<Class>
G01N33/58
</Class>
</IPC>
<NCL>
<Class>
B82Y15/00
</Class>
<Class>
G01N33/533
</Class>
<Class>
G01N33/58J
</Class>
</NCL>
<Abstract>
The invention provides a luminescent particle and a method of detecting a biological entity using a luminescent particle, the luminescent particle comprising a core area and a shell area, the core area being covered by the shell area, the core area conferring a luminescent behavior on the luminescent particle for at least one excitation wavelength and for at least one emission wavelength by means of a nanocrystal material, and the shell area being provided such that it realizes an antireflective coating of the core area.
</Abstract>
<Claims>
<P>
CLAIMS:
</P>
<P>
1. Luminescent particle (10) comprising a core area (20) and a shell area (30), the core area (20) being covered by the shell area (30), the core area (20) conferring a luminescent behavior on the luminescent particle (10) for at least one excitation wavelength (40) and for at least one emission wavelength (50) by means of a nanocrystal material (21), and the shell area (30) being provided such that it realizes an antireflective coating (31) of the core area (20).
</P>
<P>
2. Luminescent particle (10) according to claim 1, wherein the core area (20) is provided as a quantum dot structure realized by means of a non-Cd-based nanocrystal material (21).
</P>
<P>
3. Luminescent particle (10) according to claim 1 , wherein the core area (20) is provided as a quantum dot structure realizsed by means of a non-toxic nanocrystal material (21).
</P>
<P>
4. Luminescent particle (10) according to claim 1, 2 or 3, wherein the shell area (30) is provided as a non-Cd-based material and/or a non-toxic material.
</P>
<P>
5. Luminescent particle (10) according to claim 1, wherein the core area (20) is provided as a quantum dot structure realized by means of an InP-based-material.
</P>
<P>
6. Luminescent particle (10) according to claim 1, wherein the excitation wavelength (40) and the emission wavelength (50) are provided in the near infrared portion (51) of the electromagnetic spectrum.
</P>
<P>
7. Luminescent particle (10) according to claim 6, wherein the excitation wavelength (40) and the emission wavelength (50) are provided in a spectral window of minimal infra red absorption in main components of human tissue, especially in human tissue liquid and/or lipid.
</P>
<P>
8. Luminescent particle (10) according to claim 7, wherein the excitation wavelength (40) and the emission wavelength (50) are provided between 700 nm and 800 nm.
</P>
<P>
9. Luminescent particle (10) according to claim 6 or 7, wherein the excitation wavelength (40) is provided around 720 nm and/or the emission wavelength (50) is provided around 780 nm.
</P>
<P>
10. Luminescent particle (10) according to claim 6 or 7, wherein the excitation wavelength (40) and the emission wavelength (50) are separated by approximately 60 nm.
</P>
<P>
11. Luminescent particle (10) according to claim 1 , wherein the thickness (D) of the shell area (30) is provided substantially homogeneously around the core area (20).
</P>
<P>
12. Luminescent particle (10) according to claim 11 , wherein the thickness (D) of the shell area (30) is provided such that the reflectance of excitation radiation (41) and/or the reflectance of emission radiation (51) between the inside of the core area (20) and the outside of the luminescent particle (10) is comparatively low.
</P>
<P>
13. Luminescent particle (10) according to claim 1 , wherein the thickness (D) of the shell area (30) is at least partially provided such that the reflectance of excitation radiation (41) and/or the reflectance of emission radiation (51) between the inside of the core area (20) and the outside of the luminescent particle (10) is comparatively low.
</P>
<P>
14. Luminescent particle (10) according to claim 12 or 13, wherein the thickness (D) of the shell area (30) is provided such that the transmittance of excitation radiation (41) and/or the transmittance of emission radiation (51) between the inside of the core area (20) and the outside of the luminescent particle (10) is higher than 50% below, preferably higher than 25% below, most preferably higher than 10% below the maximum transmittance for a given first index of refraction (ni) of the nanocrystal material (21), a given second index of refraction (n2) of the antireflective coating (31), and a given third index of refraction (n3) of the environment of the luminescent particle (10).
</P>
<P>
15. Luminescent particle (10) according to claim 1, wherein the shell area (30) comprises a dielectric material (31).
</P>
<P>
16. Luminescent particle (10) according to claim 15, wherein the dielectric material (31) is provided as TiO2 and/or GaP and/or InGaP2 and/or other ternary compound(s).
</P>
<P>
17. Complex comprising a luminescent particle (10) according to claim 1 and further comprising a labeling substrate (110).
</P>
<P>
18. Contrast agent comprising a luminescent particle (10) according to claim 1 or a complex according to claim 17 or a mixture thereof.
</P>
<P>
19. Method of detecting a biological entity (120) using a luminescent particle (10) comprising a core area (20) and a shell area (30), the core area (20) being covered by the shell area (30), the core area (20) conferring a luminescent behavior on the luminescent particle (10) for at least one excitation wavelength (40) and for at least one emission wavelength (50) by means of a nanocrystal material (21), and the shell area (30) being provided such that it realizes an antireflective coating (31) of the core area (20), the method comprising the steps of:
</P>
<P>
- forming a complex between the luminescent particle (10) and a labeling substrate (110) by means of a physical and/or a chemical and/or a biological binding (111),
</P>
<P>
- using the labeling substrate (110) for achieving a specific binding (121) to the biological entity (120), - irradiating at least the complex of the luminescent particle (10) and the labeling substrate (110) with radiation of the excitation wavelength (40), and
</P>
<P>
- detecting the biological entity (120) by means of radiation emitted by the luminescent particle (10).
</P>
<P>
20. Method according to claim 19, wherein the complex of the luminescent particle (10) and a labeling substrate (110) is used in vivo.
</P>
<P>
21. Method according to claim 19, wherein the complex of the luminescent particle (10) and the labeling substrate (110) is used in vitro.
</P>
<P>
22. Use of the luminescent particle (10) according to claim 1 in a biomedical assay and/or an in vitro application.
</P>
<P>
23. Use of a luminescent particle (10) according to claim 1 for producing a complex according to claim 17 or a contrast agent according to claim 18 for use in a biomedical assay and/or an in vitro assay.
</P>
</Claims>
<Also_published_as>
WO2007060591A2;WO2007060591A3;US2008286826A1;JP2009516763A;CN101313222A
</Also_published_as>
</BiblioData>
